Coupling ligand structure to specific conformational switches in the β2-adrenoceptor

Nature Chemical Biology

Volumn 2, Issue 8, 2006, Pages 417-422

  Yao, Xiaojie ^a   Parnot, Charles ^a   Deupi, Xavier ^a   Ratnala, Venkata R P ^a   Swaminath, Gayathri ^a   Farrens, David ^b   Kobilka, Brian ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADRENALIN; ALPRENOLOL; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOL; DOPAMINE; G PROTEIN COUPLED RECEPTOR; HALOSTACHINE; ISOPRENALINE; NORADRENALIN; RHODOPSIN; SALBUTAMOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CYTOPLASM; DRUG CONFORMATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY;

EID: 33746382921     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio801     Document Type: Article

References (22)

1. Ballesteros, J.A. et al. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171-29177 (2001).
2. Greasley, P.J., Fanelli, F., Rossier, O., Abuin, L. & Cotecchia, S. Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol. Pharmacol. 61, 1025-1032 (2002).
3. Shapiro, D.A., Kristiansen, K., Weiner, D.M., Kroeze, W.K. & Roth, B.L. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 277, 11441-11449 (2002).
4. Farrens, D.L., Altenbach, C., Yang, K., Hubbell, W.L. & Khorana, H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770 (1996).
5. Ghanouni, P. et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J. Biol. Chem. 276, 24433-24436 (2001).
6. Swaminath, G. et al. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. J. Biol. Chem. 279, 686-691 (2004).
7. Swaminath, G. et al. Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J. Biol. Chem. 280, 22165-22171 (2005).
8. Mansoor, S.E., McHaourab, H.S. & Farrens, D.L. Mapping proximity within proteins using fluorescence spectroscopy. A study of T4 lysozyme showing that tryptophan residues quench bimane fluorescence. Biochemistry 41, 2475-2484 (2002).
9. Green, S.A., Cole, G., Jacinto, M., Innis, M. & Liggett, S.B. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268, 23116-23121 (1993).
10. Shi, L. et al. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277, 40989-40996 (2002).
11. Ruprecht, J.J., Mielke, T., Vogel, R., Villa, C. & Schertler, G.F. Electron crystallography reveals the structure of metarhodopsin I. EMBO J. 23, 3609-3620 (2004).
12. Hoffmann, C. et al. A FIAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat. Methods 2, 171-176 (2005).
13. Vilardaga, J.P., Steinmeyer, R., Harms, G.S. & Lohse, M.J. Molecular basis of inverse agonism in a G protein-coupled receptor. Nat. Chem. Biol. 1, 25-28 (2005).
14. Jongejan, A. et al. Linking agonist binding to histamine H1 receptor activation. Nat. Chem. Biol. 1, 98-103 (2005).
15. Parnot, C., Miserey-Lenkei, S., Bardin, S., Corvol, P. & Clauser, E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13, 336-343 (2002).
16. Gether, U. et al. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J. 16, 6737-6747 (1997).
17. Kobilka, B.K. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal. Biochem. 231, 269-271 (1995).
18. Ballesteros, J. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366-428 (1995).
19. Li, J., Edwards, P.C., Burghammer, M., Villa, C. & Schertler, G.F. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343, 1409-1438 (2004).
20. Wang, J., Wolf, R.M., Caldwell, J.W., Kollman, P.A. & Case, D.A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157-1174 (2004).
21. Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
22. Merritt, E.A. & Bacon, D.J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277, 505-524 (1997).